U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07142096) titled 'WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer' on July 15.
Brief Summary: The purpose of the study is to validate biomarkers in blood and tumor biopsy in patients with Triple Negative Breast Cancer, after a course of MitoQ treatment
Study Start Date: July 20
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervention:
DIETARY_SUPPLEMENT: MitoQ (mitoquinol mesylate)
Dietary supplement course before surgery or chemo/radio-therapy
Recruitment Status: RECRUITING
Sponsor: Universite Catholique de Louvain
Published by HT Digital Content Services with permission from Health Daily Digest....